Published by Josh White on 7th December 2023
(Sharecast News) - Iron deficiency-focussed pharmaceuticals company Shield Therapeutics announced significant achievements in the US commercialisation of Accrufer on Thursday.
URL: http://www.digitallook.com/dl/news/story/33958051/...